Most Awaited Q3 Sale is back. Upto 30% discount on every report.

Tissue Level Implant Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 January 24
SKU : MD4253
180 pages
Report Summary
Table of Contents
List of Tables & Figures

Tissue Level implant Market is segmented By Materials(Zirconia, Titanium and Others), By End-User(Hospita, Dental Clinics, Ambulatory Surgery Center and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029.

Tissue Level implant Market size is estimated to reach at a high CAGR during the forecast period 2023-2030. Tissue-level implants usually have a collar with a smooth titanium surface. The platforms of the implants are usually located 1.5 to 3 mm above the bone level, which is to decrease in resorption of bone at the crest.

Tissue Level implant Market



Market CAGR

Tissue Level implant Market size is estimated to reach at a high CAGR during the forecast period 2022-2029.

Segments Covered

By Materials, By End-User, and By Region

Report Insights Covered

Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.

Fastest Growing Region

Asia Pacific

Largest Market Share 

North America

Market Dynamics

Rising geriatric population and burden of dental diseases are expected to drive the market growth

Oral health is a fundamental human right as an essential component of health. It contributes to the physical, mental, and social well-being of a person and significantly impacts the quality of life. A high prevalence of edentulism has characterized the oral health of older adults in Brazil. The number and percentage of older adults in most countries around the world are rapidly increasing. According to the 2010 Brazilian Oral Health Survey, the latest available survey from a nationally representative sample, 53.7% of the adults aged 65–74 years were edentulous.

Moreover, this survey revealed a strong social gradient, with older adults from the lower socioeconomic groups experiencing edentulism five times more frequently than older adults from the highest group. The prevalence of root caries among older adults was 13.6%. Additionally, the 2019 GBD study revealed a prevalence of edentulism of 68.1%, with 7.9 million Brazilians aged 70 or above experiencing edentulism, amounting to more than 211,000 years lived with disability. In the same study, the prevalence of untreated dental caries and periodontitis in older adults were 22.2 and 14.5%, respectively. Therefore, it has increased the demand for tissue-level implants, which is expected to drive the market in the forecast period.

Difficulties of tissue implants are expected to hamper the market's growth.

Crestal bone loss (CBL) around the neck of dental implants remains one of the most common problems following implant placement. It influences the future success of the implant—preservation of crestal bone results in stable soft tissues, which is critical for long-term implant survival.

Moreover, several factors have been attributed to CBL, including surgical trauma during implant bed preparation and implant insertion, reduced thickness of buccal bone, reduced thickness of soft tissue at the implant site, stresses from occlusal loads at the implant neck, localized inflammatory reaction as a result of microleakage at the implant-abutment junction (IAJ) and reestablishment of the biological width. Additionally, these implants are the visibility of the metallic collar of the implant, resulting in an unesthetic appearance when the gingival tissue is thin. Thus, from the above statements, the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The pandemic caused by the SARS-CoV-2 virus led to a near-worldwide lockdown, had a disastrous impact on daily dental services, and completely changed the future approach towards medicine and dentistry. COVID-19 is an airborne infection spread by airborne particles (aerosols) and through physical contact by this problem because the majority of the treatments use high-speed and ultrasonic devices that generate aerosols in the treatment room, increasing the risk of respiratory transmissions.

Social distancing restricts the spread of the virus. Still, this approach is impossible in dentistry, where practitioners are always in close contact with their patients during treatments. Implant dentistry is a specific and popular profession in dentistry that shuns the use of high-speed handpieces and, therefore, the generation of aerosols, providing the treatments to be performed in a sterile surgical environment. This aseptic surgical procedure is strictly indicated for splitting the periosteum from the underlying bone. Moreover, the COVID-19 pandemic made healthcare professionals – and implant dentists in particular – take extra measures to deliver exceptional care in the safest possible environment. Protocols were reassessed, adapted and rewritten to fulfill the requirements to stop the spread of the coronavirus. Additionally, it has clinically impacted reducing the number of appointments, avoiding specific treatment options, applying extra tools and implementing new techniques. Thus, the market will undergo impetus during the forecast period.

Segment Analysis

Zirconia segment is expected to hold the largest market share in this market segment.

The zirconia segment is estimated for the largest market share in 2020. The segment growth benefits as they are more brittle than titanium and have a lower fracture and flexural strength, growing awareness among people, increasing number of dental problems, new product launches by market players are expected to boost the market in the forecast period. For instance, The first generation of zirconia implants had rather smooth implant surfaces. Consequently, it showed reduced implant survival rates compared with micro-rough titanium implants. Later on, improved manufacturing processes allowed the creation of micro-rough surface topographies on zirconia implants. The osseointegration capacity of zirconia implants has been improved. Experimental studies have shown that the latest zirconia implants with micro-rough surfaces show the same hard tissue integration as titanium implants. The latest generation of zirconia implant surface topography created by mild sandblasting followed by an acid-etching process is comparable to the sandblasted and acid-etched surface of titanium implants.

Moreover, according to TBR Implants Group, zirconia and pure titanium play an essential role in stabilizing soft tissues and in perfect osseointegration. With an average success rate of 98.6%, it can rely on the efficiency of Z1. Additionally, zirconia emergence of the Z1 behaves as a protective shield for both crestal bone and gingiva, preventing any inflammatory or infectious phenomena and ensures better aesthetic management of the gingival tissue by generating a creeping attachment of the gingiva and a reconstruction of the papillae. Whereas Z1 is placed in the anterior position, there is no greyish transparency, and Z1 is placed in the posterior position, the zirconia platform optimizes the cervical limits of your prosthetic rehabilitation. Therefore, due to the above factors, there is an increase in the demand for tissue-level implants, which is expected to hold the largest market share in the forecast period.    

Geographical Analysis

North America region holds the largest market share in the global tissue level implant market.

North America accounted for the largest revenue share in 2020. The region’s growth benefits from the increasing prevalence of periodontal diseases, rise in the geriatric population facing oral problems, presence of some of the key players and their increasing investments and new product launches are the factors that are expected to boost the market in the forecast period. For instance, according to the Centers for Disease Control and Prevention (CDC), periodontitis is a chronic disease with an infectious etiology, causing an inflammatory response resulting in the breakdown of soft and hard tissues around teeth. Severe periodontitis has been identified as the sixth most prevalent disease in the world. In the USA, the prevalence of periodontitis is half of Americans aged 30 or older. It equals approximately 64.7 million Americans. Moreover, the accumulation of dental plaque and tartar, associated with poor oral hygiene, is one of the risk factors in developing periodontal disease. This accumulation predictably causes gingival inflammation, which, if persistent, can lead to the breakdown of the periodontal attachment and thus to periodontal disease.

Additionally, in several studies, it has been observed that there is a dose-response relationship between oral hygiene and periodontitis. Thus, average and poor oral hygiene significantly increases the risk of periodontitis by two and five times, respectively, compared to good OH. In contrast, regular tooth brushing and visits to the dentist could reduce periodontitis by 34% and 32%, respectively. In most cases, plaque accumulation could result from incorrect brushing techniques, failure to clean interdentally and periodic dental visits. In another study, regular brushing is observed to have protective effects on oral health, with infrequent tooth brushing increasing periodontitis risk.

Periodontitis has been associated with an increased risk for CVDs, especially in men and younger subjects. In a control-matched study by Rydén et al. 2016, an increased risk for a first myocardial infarction was reported among individuals with periodontitis. Therefore, it has led to an increase in the demand for tissue-level implants, which are expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the tissue level implant market are Straumann AG, Implantswiss, BioHorizons, Biotec, Megagen, Dentsply Sirona, Novodent and TBR Implants Group.

Straumann AG:


Straumann, headquartered in Basel, Switzerland, researches and develops, manufactures and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement restorative, orthodontic and preventative dentistry. Moreover, the Straumann Group also offers services to the dental profession worldwide, including training and education, which is provided in collaboration with the International Team for Implantology (ITI) and the Instituto Latino Americano de Pesquisa e Ensino Odontológico (ILAPEO). Altogether, the Straumann Group employs approximately 6,000 people worldwide, and its products and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.

Product Portfolio:

Straumann Tissue Level Implant Line: It is designed for one-stage surgery to simplify handling and reduce treatment complexity, and it preserves peri-implant health.

Straumann TLX Implant System: It is a fully tapered implant design for optimized primary stability combined with the predictability of Tissue Level Implant with a diameter option, 3.75 mm for all indications.

Trending Topics

Clear Aligners Market

Dental Floss Market

Dental Lithium Disilicate Market

Buy this report
Single User
Multiple User
Enterprise User
Proceed to Buy
Request new version